HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

G Belcaro Selected Research

Varicose Ulcer (Ulcer, Venous)

9/2011TECA (Titrated Extract of Centella Asiatica): new microcirculatory, biomolecular, and vascular application in preventive and clinical medicine. A status paper.
9/2011Silver oxide ointment wound dressing in venous ulcerations: home, self-management.
6/2010Venous and diabetic ulcerations: management with topical multivalent silver oxide ointment.
6/2010Faster healing of venous ulcers with crystacide: a clinical and microcirculatory 8-week registry study.
11/2005Venous ulcers: microcirculatory improvement and faster healing with local use of Pycnogenol.
5/2003Improvement of microcirculation and healing of venous hypertension and ulcers with Crystacide. Evaluation of free radicals, laser Doppler flux and PO2. A prospective-randomized-controlled study.
1/2002Treatment of venous ulcers with pentoxifylline: a 6-month randomized, double-blind, placebo controlled trial.
1/2002Treatment of venous ulcers with pentoxifylline: a 12-month, double-blind, placebo controlled trial. Microcirculation and healing.
12/2001Changes in microcirculation in venous ulcers with Essaven gel--a pilot, cross-over, placebo-controlled, randomized study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


G Belcaro Research Topics

Disease

31Edema (Dropsy)
09/2017 - 10/2001
25Hypertension (High Blood Pressure)
10/2013 - 08/2000
17Venous Insufficiency
09/2010 - 10/2001
14Pain (Aches)
12/2016 - 08/2000
14Diabetic Angiopathies (Diabetic Angiopathy)
10/2016 - 10/2001
12Thrombosis (Thrombus)
09/2011 - 08/2000
11Varicose Veins (Varicose Vein)
09/2011 - 12/2001
11Ulcer
09/2011 - 12/2001
10Venous Thrombosis (Deep-Vein Thrombosis)
01/2018 - 07/2003
9Intermittent Claudication
08/2012 - 08/2000
9Varicose Ulcer (Ulcer, Venous)
09/2011 - 12/2001
6Wounds and Injuries (Trauma)
10/2017 - 12/2001
6Vascular Diseases (Vascular Disease)
10/2008 - 08/2000
5Osteoarthritis
01/2018 - 01/2008
5Inflammation (Inflammations)
12/2016 - 09/2011
5Tinnitus
06/2014 - 01/2002
5Infections
12/2012 - 08/2000
4Ankle Injuries (Ankle Injury)
10/2017 - 11/2005
4Liver Failure
10/2015 - 02/2014
3Hematoma
10/2016 - 12/2001
3Atherosclerosis
04/2015 - 08/2000
3Metabolic Syndrome (Dysmetabolic Syndrome X)
10/2013 - 10/2008
3Vertigo (Positional Vertigo)
06/2010 - 01/2002
3Thrombophlebitis
04/2007 - 12/2001
2Knee Osteoarthritis
12/2016 - 01/2008
2Fatigue
06/2015 - 10/2008
2Psoriasis (Pustulosis Palmaris et Plantaris)
03/2014 - 09/2011
2Muscle Cramp (Cramp)
12/2013 - 05/2006
2Atrophy
11/2012 - 07/2000
2Cicatrix (Scar)
09/2011 - 10/2001
2Hypothyroidism
09/2011 - 09/2011
2Ischemia
09/2011 - 08/2000
2Sprains and Strains (Sprain)
10/2008 - 12/2001
2Chronic Limb-Threatening Ischemia
07/2005 - 08/2000
2Labyrinth Diseases
01/2002 - 01/2002
2Dizziness (Lightheadedness)
01/2002 - 01/2002
2Cardiovascular Diseases (Cardiovascular Disease)
06/2001 - 09/2000
1Ocular Hypertension (Glaucoma, Suspect)
10/2017
1Urogenital Neoplasms
09/2017
1Neoplasms (Cancer)
09/2017

Drug/Important Bio-Agent (IBA)

24pycnogenolsIBA
09/2017 - 10/2004
12Essaven GelIBA
12/2001 - 12/2001
11TECAIBA
04/2015 - 10/2001
11troxerutinIBA
06/2010 - 01/2002
11Pentoxifylline (Trental)FDA LinkGeneric
01/2002 - 01/2002
8CurcuminIBA
01/2018 - 06/2010
7EscinIBA
10/2016 - 05/2004
7Heparin (Liquaemin)FDA LinkGeneric
09/2011 - 05/2004
6Free RadicalsIBA
01/2008 - 06/2001
5Retinaldehyde (Retinal)IBA
10/2017 - 01/2002
5AntioxidantsIBA
10/2015 - 01/2008
5Alprostadil (Muse)FDA LinkGeneric
08/2012 - 08/2000
5essential 303 forteIBA
05/2004 - 05/2004
4LecithinsIBA
01/2017 - 01/2014
45,11-methenyltetrahydrohomofolateIBA
10/2015 - 02/2014
4CollagenIBA
09/2011 - 10/2001
3AnticoagulantsIBA
01/2018 - 04/2007
3Dihydrotachysterol (AT 10)IBA
12/2012 - 05/2003
3Pharmaceutical PreparationsIBA
09/2011 - 10/2001
3Diosmin (Daflon)IBA
04/2006 - 07/2002
3Fibrinolytic Agents (Antithrombotic Agents)IBA
07/2005 - 05/2004
2Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
01/2018 - 09/2015
2AcidsIBA
10/2017 - 10/2016
2TabletsIBA
10/2017 - 10/2001
2Pain-FreeIBA
12/2016 - 10/2016
2Biomarkers (Surrogate Marker)IBA
12/2016 - 10/2016
2Triglycerides (Triacylglycerol)IBA
10/2013 - 10/2008
2Sclerosing Solutions (Sclerosing Agents)IBA
12/2012 - 08/2003
2fibrin fragment D (D-dimer)IBA
12/2012 - 09/2011
2Phospholipids (Phosphatides)FDA LinkGeneric
12/2012 - 06/2010
2Thyroxine (Levothyroxine)FDA LinkGeneric
09/2011 - 09/2011
2Ointments (Pastes)IBA
09/2011 - 06/2010
2disilver oxideIBA
09/2011 - 06/2010
2Oxygen (Dioxygen)IBA
09/2011 - 11/2005
2Lipoproteins (Lipoprotein)IBA
06/2010 - 06/2001
2CrystacideIBA
06/2010 - 05/2003
2Ketoprofen (Orudis)FDA LinkGeneric
10/2008 - 10/2008
2Fibrinogen (Factor I)FDA Link
01/2008 - 09/2000
2HesperidinIBA
04/2006 - 03/2006
2Proteins (Proteins, Gene)FDA Link
07/2005 - 08/2000
2lercanidipineIBA
06/2001 - 08/2000
2Prostaglandins EIBA
08/2000 - 08/2000
1Thyroid HormonesIBA
01/2018
1DabigatranFDA Link
01/2018
1Warfarin (Coumadin)FDA LinkGeneric
01/2018
1Latanoprost (Xalatan)FDA Link
10/2017
1Ophthalmic Solutions (Eye Drops)IBA
10/2017
1AntistaxIBA
09/2017
1astaxanthine (astaxanthin)IBA
09/2017

Therapy/Procedure

10Lasers (Laser)
12/2012 - 10/2001
8Therapeutics
01/2018 - 06/2010
5Compression Stockings
09/2011 - 07/2003
3Sclerotherapy
09/2011 - 05/2003
3Ligation
05/2003 - 07/2000
3Aftercare (After-Treatment)
01/2002 - 10/2001
2Drug Therapy (Chemotherapy)
09/2017 - 10/2015
2Thrombolytic Therapy
12/2012 - 10/2008
2Sutures (Suture)
09/2011 - 08/2000
1Immunotherapy
09/2017
1Radiotherapy
09/2017